• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国癌症登记处治疗数据的完整性:对护理质量研究的影响。

Completeness of American Cancer Registry Treatment Data: implications for quality of care research.

机构信息

Commission on Cancer, American College of Surgeons, Chicago, IL, USA.

出版信息

J Am Coll Surg. 2013 Mar;216(3):428-37. doi: 10.1016/j.jamcollsurg.2012.12.016. Epub 2013 Jan 26.

DOI:10.1016/j.jamcollsurg.2012.12.016
PMID:23357724
Abstract

BACKGROUND

Evaluating and improving the quality of cancer care requires complete information on cancer stage and treatment. Hospital-based registries are a key tool in this effort, but reports in the 1990s showed that they fail to identify a major fraction of outpatient-administered treatment, including chemotherapy, endocrine therapy, and radiation. This can limit their value for evaluating patterns and quality of care. To determine the completeness of registry data in more recent years, we linked administrative claims from 2 private payers in Ohio to the National Cancer Data Base and Ohio Cancer Incidence and Surveillance System.

METHODS

Incident breast and colorectal cancers among Ohio residents diagnosed in 2004-2006 were identified from linkage of the National Cancer Data Base, Ohio Cancer Incidence and Surveillance System, and payer insurance claims using ICD-9 and CPT procedure codes, and ICD-9 diagnosis codes. Linkage was accomplished using patient demographics, surgery dates, and hospital facility. Treatment found in claims and registry data were compared and assessed using the κ statistic.

RESULTS

The analytic cohort included 2,552 breast and 822 colorectal cases. Results showed high agreement for breast surgery type, and moderately high agreement for colorectal surgery type. For breast cases, the registries captured 87% of chemotherapy, 86% of radiation, and 64% of endocrine treatment in claims. For colorectal cases, the registry captured 83% of chemotherapy and 84% of radiation in claims.

CONCLUSIONS

Hospital-based registries for breast and colon cancer diagnosed in 2004-2006 captured about 85% of radiation and chemotherapy data compared with claims data, a higher percentage than earlier reports. These findings provide direction and a cautionary note to those using registry data for study of patterns and quality of systemic and radiation therapy care.

摘要

背景

评估和提高癌症护理质量需要全面了解癌症分期和治疗情况。医院为基础的登记处是这方面的重要工具,但 20 世纪 90 年代的报告显示,它们未能识别出很大一部分门诊治疗,包括化疗、内分泌治疗和放疗。这可能限制了它们在评估护理模式和质量方面的价值。为了确定近年来登记处数据的完整性,我们将俄亥俄州的两家私人支付者的行政索赔与国家癌症数据库以及俄亥俄州癌症发病率和监测系统联系起来。

方法

通过使用 ICD-9 和 CPT 程序代码以及 ICD-9 诊断代码,从国家癌症数据库、俄亥俄州癌症发病率和监测系统以及支付者保险索赔中对 2004-2006 年间诊断的俄亥俄州居民的乳腺癌和结直肠癌病例进行链接,确定了事件性乳腺癌和结直肠癌病例。链接是通过患者人口统计学、手术日期和医院设施完成的。使用κ统计量比较和评估索赔和登记处数据中的治疗方法。

结果

分析队列包括 2552 例乳腺癌和 822 例结直肠癌病例。结果表明,乳腺癌手术类型的一致性很高,结直肠癌手术类型的一致性较高。对于乳腺癌病例,登记处记录了索赔中 87%的化疗、86%的放疗和 64%的内分泌治疗。对于结直肠癌病例,登记处记录了索赔中 83%的化疗和 84%的放疗。

结论

2004-2006 年间诊断的乳腺癌和结肠癌的医院为基础的登记处与索赔数据相比,大约记录了 85%的放疗和化疗数据,比早期报告的比例更高。这些发现为那些使用登记处数据研究系统治疗和放疗护理模式和质量的人提供了方向和警示。

相似文献

1
Completeness of American Cancer Registry Treatment Data: implications for quality of care research.美国癌症登记处治疗数据的完整性:对护理质量研究的影响。
J Am Coll Surg. 2013 Mar;216(3):428-37. doi: 10.1016/j.jamcollsurg.2012.12.016. Epub 2013 Jan 26.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancer.成年癌症患者在家中与在医院或社区环境中接受静脉抗癌治疗的情况。
Cochrane Database Syst Rev. 2025 Apr 22;4(4):CD014861. doi: 10.1002/14651858.CD014861.pub2.
8
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.用于预防或治疗早期乳腺癌中芳香化酶抑制剂引起的肌肉骨骼症状的系统治疗。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD013167. doi: 10.1002/14651858.CD013167.pub2.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.

引用本文的文献

1
Comparison of incident breast cancer cases in the largest national US tumor registries.美国最大的国家肿瘤登记处中乳腺癌新发病例的比较。
Cancer. 2025 Jan 1;131(1):e35525. doi: 10.1002/cncr.35525. Epub 2024 Aug 18.
2
Survival among patients with untreated metastatic breast cancer: "What if I do nothing?".未经治疗的转移性乳腺癌患者的生存:“如果我什么都不做会怎样?”
Breast Cancer Res Treat. 2024 Jun;205(2):333-347. doi: 10.1007/s10549-024-07265-2. Epub 2024 Mar 5.
3
Implications of missing data on reported breast cancer mortality.报告乳腺癌死亡率数据缺失的影响。

本文引用的文献

1
Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2013 rates; hospitals' resident caps for graduate medical education payment purposes; quality reporting requirements for specific providers and for ambulatory surgical centers. final rule.医疗保险计划;急症医院的住院病人前瞻性支付系统、长期护理医院前瞻性支付系统及2013财年费率;用于研究生医学教育支付目的的医院住院医生上限;特定提供者及门诊手术中心的质量报告要求。最终规则。
Fed Regist. 2012 Aug 31;77(170):53257-750.
2
Adherence to stage-specific treatment guidelines for patients with colon cancer.结肠癌患者遵循特定阶段的治疗指南。
J Clin Oncol. 2012 Mar 20;30(9):972-9. doi: 10.1200/JCO.2011.39.6937. Epub 2012 Feb 21.
3
Breast Cancer Res Treat. 2023 Jan;197(1):177-187. doi: 10.1007/s10549-022-06764-4. Epub 2022 Nov 5.
4
The use of electronic health records to inform cancer surveillance efforts: a scoping review and test of indicators for public health surveillance of cancer prevention and control.利用电子健康记录为癌症监测工作提供信息:一项用于癌症预防和控制公共卫生监测的指标的探索性综述和测试。
BMC Med Inform Decis Mak. 2022 Apr 6;22(1):91. doi: 10.1186/s12911-022-01831-8.
5
Validity of breast cancer surgery treatment information in a state-based cancer registry.基于州的癌症登记处中乳腺癌手术治疗信息的有效性。
Cancer Causes Control. 2022 Feb;33(2):261-269. doi: 10.1007/s10552-021-01520-3. Epub 2021 Nov 16.
6
Metastatic breast cancer: Who benefits from surgery?转移性乳腺癌:哪些人从手术中获益?
Am J Surg. 2022 Jan;223(1):81-93. doi: 10.1016/j.amjsurg.2021.07.018. Epub 2021 Jul 22.
7
The impact of sociodemographic factors on the utilization of radiation therapy in breast cancer patients in Estonia: a register-based study.社会人口因素对爱沙尼亚乳腺癌患者放疗利用的影响:基于登记的研究。
Int J Equity Health. 2021 Jun 30;20(1):152. doi: 10.1186/s12939-021-01497-0.
8
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.癌症和 COVID-19 患者数据快速获取的系统框架:CCC19 治理、方案和质量保证。
Cancer Cell. 2020 Dec 14;38(6):761-766. doi: 10.1016/j.ccell.2020.10.022. Epub 2020 Oct 29.
9
Surgery for Men with Breast Cancer: Do the Same Data Still Apply?男性乳腺癌的外科治疗:同样的数据仍然适用吗?
Ann Surg Oncol. 2020 Nov;27(12):4720-4729. doi: 10.1245/s10434-020-08901-z. Epub 2020 Jul 23.
10
Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis.真实世界中 HR+/HER2+转移性乳腺癌患者的治疗模式和结局:一项全国癌症数据库分析。
Sci Rep. 2019 Dec 2;9(1):18126. doi: 10.1038/s41598-019-54402-9.
Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States.美国胃胃肠道间质瘤多模式治疗中辅助治疗的应用。
Ann Surg Oncol. 2012 Jan;19(1):184-91. doi: 10.1245/s10434-011-1842-9. Epub 2011 Jul 2.
4
Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data.监测、流行病学和最终结果注册数据中放疗接收情况的低估。
Cancer. 2012 Jan 15;118(2):333-41. doi: 10.1002/cncr.26295. Epub 2011 Jun 29.
5
All-payer claims databases: state initiatives to improve health care transparency.全支付方索赔数据库:提高医疗保健透明度的州级举措。
Issue Brief (Commonw Fund). 2010 Sep;99:1-14.
6
Rapid-learning system for cancer care.癌症护理快速学习系统。
J Clin Oncol. 2010 Sep 20;28(27):4268-74. doi: 10.1200/JCO.2010.28.5478. Epub 2010 Jun 28.
7
Claims data linked to hospital registry data enhance evaluation of the quality of care of breast cancer.索赔数据与医院注册数据相关联,可以提高乳腺癌护理质量的评估。
J Surg Oncol. 2010 Jun 1;101(7):593-9. doi: 10.1002/jso.21528.
8
The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.国家癌症数据库:一项改善美国癌症护理的有力举措。
Ann Surg Oncol. 2008 Mar;15(3):683-90. doi: 10.1245/s10434-007-9747-3. Epub 2008 Jan 9.
9
Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews.肿瘤登记处提供的化疗和激素治疗信息与病历审查结果具有中度一致性。
J Clin Epidemiol. 2006 Jan;59(1):53-60. doi: 10.1016/j.jclinepi.2005.06.002. Epub 2005 Sep 30.
10
Understanding interobserver agreement: the kappa statistic.理解观察者间一致性:kappa统计量。
Fam Med. 2005 May;37(5):360-3.